Clinical Trials · NCT05756764
Anti-obesity Pharmacotherapy and Inflammation
Active Not RecruitingN/ATirzepatide (Investigational)Semaglutide (Investigational)Liraglutide (Investigational)
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Enrollment
- 30
- Start date
- Jun 2023
- Locations
- 2 sites, United States
- Primary endpoint
- weight loss